Clinical trial IMBrella
An open label, multicenter extension study in patients previously enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd sponsored atezolizumab study (IMBRELLA B)
Cancers | |
---|---|
Organ | Multiple |
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 4 |
Academic trial | Non |
Sponsor | Roche |
EudraCT Identifier | 2018-003352-20 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03768063 |
Inclusion criteria | Participated in parent study |
Last update |